LACTASE ENZYME DIN 02237790
Status: Cancelled Post Market
Holder: HOLISTA HEALTH (CANADA) INC.
Molecule: BETA-GALACTOSIDASE
Available to quote
Health Canada record
| Active ingredient(s) | BETA-GALACTOSIDASE 3300 UNIT |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 13-Apr-1998 |
| Current status date | 06-Aug-2002 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Request a quote for LACTASE ENZYME